Lack of Electrocardiographic Effects of Deucravacitinib in Healthy Subjects.
Chimalakonda A, Singhal S, Darbenzio R, Dockens R, Marchisin D, Banerjee S, Girgis IG, Throup J, He B, Aras U, Murthy B.
Chimalakonda A, et al. Among authors: singhal s.
Clin Pharmacol Drug Dev. 2022 Apr;11(4):442-453. doi: 10.1002/cpdd.1056. Epub 2022 Feb 19.
Clin Pharmacol Drug Dev. 2022.
PMID: 35182043
Free PMC article.
Clinical Trial.